APRETUDE (cabotegravir) is a prescription medicine used for HIV-1 PrEP to reduce the risk of getting HIV-1 infection in adults and adolescents who weigh at least 77 pounds (at least 35 kg).
APRETUDE is manufactured by GlaxoSmithKline.
Administration and Dosage:
APRETUDE is given every other month by a healthcare provider after initiation injections have been given 1 month apart for 2 consecutive months
Common Side Effects:
Pain, tenderness, hardened mass or lump, swelling, bruising, redness, itching, warmth, loss of sensation at the injection site, abscess, and discoloration; diarrhea; headache; fever; tiredness; sleep problems; nausea; dizziness; passing gas; stomach pain; vomiting; muscle pain; rash; loss of appetite; drowsiness; back pain; or upper respiratory infection
These are not all the possible side effects of APRETUDE. Call your healthcare provider for medical advice about side effects
Please read the full Prescribing Information for ACTEMRA® and discuss any questions you have with your doctor.
Ready to Schedule an Appointment?
Please CLICK HERE to get started.
APRETUDE is indicated to treat: